|
Zednik stable after carotid artery severed in Panthers-Sabres game
He was conscious, I guess, that's what the trainer said. His eyes were closed, but he was moving and moaning." Zednik's injury was eerily reminiscent of an injury sustained by Sabres goaltender Clint Malarchuk about 19 years ago at Buffalo's Memorial Auditorium. On March 22, 1989, Malarchuk severed his jugular vein when St. Louis Blues forward Steve Tuttle was upended while skating toward the crease, slicing Malarchuk with a skate. "I was back here watching, and I knew what it was right away," Sabres longtime equipment manager Rip Simonick told The Buffalo News. "Just like that night." Malarchuk required over 300 stitches but spent only one night in the hospital, returning to practice after four days. On April 2, he played the final five minutes in the season finale, less than two weeks after his injury.
Adjusting to a new life
Major professional sports are filled with young men who were raised in a street culture where Air Force Ones are regarded as dress shoes, the N-word is a term of endearment and self-worth is derived from what you wear and drive. They have been indoctrinated with morals based on unique concepts of loyalty, respect and rebellion. But, being professional athletes, or even big-time college athletes, they're expected to adopt mainstream culture. Immediately. .
McCain and Rove form a tentative alliance
We never had any ill will after the initial South Carolina thing. After we had the meeting with President Bush we moved on. I've seen Karl Rove many times when I've been over at the White House. We've always had pleasant conversations." A transcript of McCain's remarks is below, followed by the video of the event: QUESTION: Are there other signs you see that are encouraging to you... MCCAIN: Oh yeah. A lot of the fundraisers from other camps are coming on board. And yeah we're seeing that coming together really well. We're seeing it. [Inaudible] MCCAIN: Who? QUESTION: Karl Rove? MCCAIN: Oh I, listen, he ah. Nobody denies he's one of the smartest political minds in America. I'd be glad to get his advice.
Sarah Connor Chronicles Terminates the Competition
Though my housemates thought Terminator: The Sarah Connor Chronicles would flop, what the hell do they know? While I must admit that I was (and remain) doubtful, the show's series premiere scored big with audiences.
The Sarah Connor Chronicles Opens Big
Terminator: The Sarah Connor Chronicles scored the best opening night demo ratings of any new show in three years.
Thanks in part to strong, aka expensive, marketing, Connor opened to an eye-popping 7.6 rating/18 share among adults 18-49 and delivered around 18.3 million viewers with its one-hour bow Sunday at 8, according to prelim Nielsen national data.
While other shows in the same slot did not perform nearly as well -- don't even get me started on the so-called Golden Globes -- Terminator performed amazingly in every way one can look at it.
Living with breast cancer
.shilink {font: 11px Arial; color: #FFFFFF; background: #EA0001} .shilink a:link {font: 11px Arial; color: #FFFFFF; text-decoration: none} .shilink a:visited {font: 11px Arial; color: #FFFFFF; text-decoration: none} .shilink a:hover {font: 11px Arial; color: #B50507; text-decoration: underline} .toppics {font: 11px Verdana; color: #000000} .toppics a:link {font: 11px Verdana; color: #000000; text-decoration: none} .toppics a:visited {font: 11px Verdana; color: #000000; text-decoration: none} .toppics a:hover {font: 11px Verdana; color: #000000; text-decoration: underline} Advertisement .
Accused of hiding drug dangers again, Big Pharma starts 2008 defending ...
Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis in the February 8 issue of Annals of Internal Medicine. They did find the newer drugs can have serious side effects such as strokes, blood clots in the lungs or bleeding in the uterus (a January 15 Journal of Rheumatology paper finds oral bisphosphonate drugs nearly triple the risk of developing bone necrosis) and that "data are insufficient to determine the relative efficacy or safety" of all the studied drugs. Some will notice the antidepressant article in the New England Journal of Medicine and bone drug article in the Annals of Internal Medicine are unusually short. They lack the obligatory six inches of drug company financial support to the researchers which most journal articles show at the end.
|
